Elite Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:ELTP)

$0.11 -0.01 (-8.25 %)
(As of 01/19/2018 04:00 PM ET)
Previous Close$0.11
Today's Range$0.11 - $0.12
52-Week Range$0.06 - $0.25
Volume1.40 million shs
Average Volume1.54 million shs
Market Capitalization$92.29 million
P/E Ratio-11.12
Dividend YieldN/A
Beta-0.38

About Elite Pharmaceuticals (OTCMKTS:ELTP)

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is principally engaged in the development and manufacture of oral, controlled-release products. The Company develops and manufactures generic products, products using controlled-release drug technology, products utilizing abuse deterrent technologies, and it develops and markets generic controlled-release and abuse deterrent pharmaceutical products. Its segments include Abbreviated New Drug Applications (ANDA's) for generic products and New Drug Applications (NDA's) for branded products. The Company owns approximately six different approved ANDA's. The Company's product, SequestOx, is an immediate-release Oxycodone Hydrochloride containing sequestered Naltrexone, which incorporates five milligram, 10 milligram, 15 milligram, 20 milligram and 30 milligram doses of oxycodone into capsules. SequestOx is used for the management of moderate to severe pain where the use of an opioid analgesic is appropriate.

Receive ELTP News and Ratings via Email

Sign-up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Other
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:ELTP
CUSIPN/A
Phone201-750-2646

Debt

Debt-to-Equity Ratio0.53%
Current Ratio4.01%
Quick Ratio2.45%

Price-To-Earnings

Trailing P/E Ratio-11.12
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$9.64 million
Price / Sales9.10
Cash Flow$0.00 per share
Price / Cash23.75
Book Value$0.03 per share
Price / Book3.71

Profitability

Trailing EPS($0.01)
Net Income$3.81 million
Net Margins-26.73%
Return on Equity-12.15%
Return on Assets-5.49%

Miscellaneous

Employees46
Outstanding Shares788,800,000

Elite Pharmaceuticals (OTCMKTS:ELTP) Frequently Asked Questions

What is Elite Pharmaceuticals' stock symbol?

Elite Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ELTP."

When will Elite Pharmaceuticals make its next earnings announcement?

Elite Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, February, 8th 2018. View Earnings Estimates for Elite Pharmaceuticals.

Who are some of Elite Pharmaceuticals' key competitors?

Who are Elite Pharmaceuticals' key executives?

Elite Pharmaceuticals' management team includes the folowing people:

  • Nasrat Hakim, Chairman of the Board, President, Chief Executive Officer (Age 53)
  • Jerry I. Treppel, Chairman of the Board (Age 60)
  • Carter Julian Ward CPA, Chief Financial Officer, Treasurer, Secretary (Age 51)
  • Douglas Plassche, Executive Vice President - Operations (Age 52)
  • Ashok G. Nigalaye Ph.D., Chief Scientific Officer, Director (Age 62)
  • George Kenneth Smith, Vice President
  • Davis S. Caskey, Director (Age 65)
  • Jeenarine Narine, Director (Age 64)
  • Eugene M. Pfeifer, Director (Age 76)
  • Barry H. Dash Ph.D., Independent Director (Age 84)

How do I buy Elite Pharmaceuticals stock?

Shares of Elite Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elite Pharmaceuticals' stock price today?

One share of Elite Pharmaceuticals stock can currently be purchased for approximately $0.11.

How big of a company is Elite Pharmaceuticals?

Elite Pharmaceuticals has a market capitalization of $92.29 million and generates $9.64 million in revenue each year. The specialty pharmaceutical company earns $3.81 million in net income (profit) each year or ($0.01) on an earnings per share basis. Elite Pharmaceuticals employs 46 workers across the globe.

How can I contact Elite Pharmaceuticals?

Elite Pharmaceuticals' mailing address is 165 LUDLOW AVENUE, NORTHVALE NJ, 07647. The specialty pharmaceutical company can be reached via phone at 201-750-2646 or via email at [email protected]


MarketBeat Community Rating for Elite Pharmaceuticals (ELTP)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Elite Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Elite Pharmaceuticals (OTCMKTS:ELTP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Elite Pharmaceuticals (OTCMKTS:ELTP) Earnings History and Estimates Chart

Earnings by Quarter for Elite Pharmaceuticals (OTCMKTS:ELTP)

Elite Pharmaceuticals (OTCMKTS ELTP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/8/2018        
6/14/2017Q4 2017($0.01)ViewN/AView Earnings Details
6/15/2016Q4 2016$0.04ViewN/AView Earnings Details
2/9/2016Q3 2016($0.05)ViewN/AView Earnings Details
6/15/2015Q4 2015($0.01)ViewN/AView Earnings Details
11/18/2014Q2 2015($0.01)ViewN/AView Earnings Details
8/14/2014Q1 2015($0.01)ViewN/AView Earnings Details
11/14/2013Q2 2014($0.02)ViewN/AView Earnings Details
2/14/2013Q3 2013$0.02ViewN/AView Earnings Details
8/14/2012Q1 2013($0.03)ViewN/AView Earnings Details
11/14/2011Q2 2012$0.03ViewN/AView Earnings Details
6/30/2011Q4 2011($0.07)ViewN/AView Earnings Details
11/15/2010Q2 2011$0.01ViewN/AView Earnings Details
8/17/2010Q1 2011($0.05)ViewN/AView Earnings Details
2/22/2010Q3 2010($0.02)ViewN/AView Earnings Details
8/12/2008Q1 2009($0.12)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Elite Pharmaceuticals (OTCMKTS:ELTP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Elite Pharmaceuticals (OTCMKTS:ELTP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Elite Pharmaceuticals (OTCMKTS ELTP) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 34.66%
Institutional Ownership Percentage: 0.01%
Insider Trades by Quarter for Elite Pharmaceuticals (OTCMKTS:ELTP)

Elite Pharmaceuticals (OTCMKTS ELTP) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2016Jerry TreppelChairmanSell570,520$0.34$193,976.807,898,651View SEC Filing  
2/24/2016Jerry TreppelChairmanSell200,456$0.32$64,145.928,311,537View SEC Filing  
2/17/2016Jerry TreppelChairmanSell909,878$0.33$300,259.748,411,537View SEC Filing  
11/18/2015Jerry TreppelChairmanSell150,000$0.30$45,000.009,196,769View SEC Filing  
4/27/2015Douglas PlasscheVPSell85,530$0.24$20,527.20View SEC Filing  
9/26/2014Nasrat A HakimCEOBuy700,000$0.31$217,000.00View SEC Filing  
4/2/2014Jeenarine NarineDirectorSell147,664$0.41$60,542.24View SEC Filing  
3/27/2014Jeenarine NarineDirectorSell190,172$0.43$81,773.96View SEC Filing  
3/7/2014Epic Pharma LlcMajor ShareholderSell1,824,500$0.77$1,404,865.00View SEC Filing  
11/19/2013Jeenarine NarineDirectorSell1,974,140$0.12$236,896.80View SEC Filing  
10/29/2013Epic Investments, LlcMajor ShareholderSell931,000$0.13$121,030.00View SEC Filing  
10/29/2013Jeenarine NarineDirectorSell204,820$0.07$14,337.40View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Elite Pharmaceuticals (OTCMKTS ELTP) News Headlines

Source:
DateHeadline
Elite Pharmaceuticals (ELTP) CEO Nasrat Hakim on Q2 2018 Results - Earnings Call TranscriptElite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 11:36 AM
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2018 Ended September 30, 2017
finance.yahoo.com - November 10 at 12:28 PM
Elite Pharmaceuticals Inc. (ELTP) Set to Announce Quarterly Earnings on ThursdayElite Pharmaceuticals Inc. (ELTP) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - November 8 at 10:14 AM
CORRECTING And REPLACING - Elite Pharmaceuticals, Inc.CORRECTING And REPLACING - Elite Pharmaceuticals, Inc.
www.thestreet.com - November 8 at 6:08 AM
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017
finance.yahoo.com - November 8 at 6:08 AM
CORRECTING and REPLACING – Elite Pharmaceuticals, Inc.CORRECTING and REPLACING – Elite Pharmaceuticals, Inc.
finance.yahoo.com - November 8 at 6:08 AM
Elite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended ReleaseElite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended Release
finance.yahoo.com - September 20 at 7:09 PM
Elite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National ConferenceElite Pharmaceuticals to Present ELI-200 (SequestOx™) Data at PAINWeek 2017 National Conference
finance.yahoo.com - August 30 at 7:29 PM
Elite Pharmaceuticals (ELTP) CEO Nasrat Hakim on Q1 2018 Results - Earnings Call TranscriptElite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - August 12 at 5:33 PM
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call InformationElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2018 Ended June 30, 2017 and Provides Conference Call Information
finance.yahoo.com - August 9 at 6:24 PM
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss First Quarter Financial Results on August 10, 2017
finance.yahoo.com - August 8 at 5:59 PM
Elite Announces Co-Development of Four Additional Products with SunGen PharmaElite Announces Co-Development of Four Additional Products with SunGen Pharma
finance.yahoo.com - July 28 at 8:17 PM
Elite Announces New Development and License Agreement with SunGen Pharma LLCElite Announces New Development and License Agreement with SunGen Pharma LLC
finance.yahoo.com - July 12 at 6:55 PM
ITEK Disappoints, ALNY Maps Out ATLAS, ENTL Opens Wallet, D-day Nearing For OCULITEK Disappoints, ALNY Maps Out ATLAS, ENTL Opens Wallet, D-day Nearing For OCUL
www.rttnews.com - July 10 at 6:07 PM
Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™Elite Pharmaceuticals Reports Topline Results from a Pivotal Fed Bioequivalence Study for SequestOx™
finance.yahoo.com - July 8 at 10:29 AM
Elite Pharmaceuticals (ELTP) CEO Nasrat Hakim on Q4 2017 Results - Earnings Call TranscriptElite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - June 15 at 6:59 PM
FinancialBuzz.com: Developments in the Biotechnology Market - PR Newswire (press release)FinancialBuzz.com: Developments in the Biotechnology Market - PR Newswire (press release)
www.prnewswire.com - February 16 at 7:43 AM
Elite Pharmaceuticals (ELTP) CEO Nasrat Hakim on Q3 2017 Results - Earnings Call TranscriptElite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - February 13 at 5:45 PM
Q3 2017 Elite Pharmaceuticals Inc Earnings Release - After Market CloseQ3 2017 Elite Pharmaceuticals Inc Earnings Release - After Market Close
us.rd.yahoo.com - February 9 at 5:31 PM
ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD DisclELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Discl
biz.yahoo.com - February 9 at 5:31 PM
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017 - NasdaqElite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2017 Financial Results on February 13, 2017 - Nasdaq
www.nasdaq.com - February 8 at 10:29 PM
Elite Reports On SequestOx™ FDA End-of-Review Meeting - GlobeNewswire (press release)Elite Reports On SequestOx™ FDA End-of-Review Meeting - GlobeNewswire (press release)
www.globenewswire.com - January 23 at 9:40 AM
FinancialBuzz.com: Recent Developments in the World of Small Cap Companies - PR Newswire (press release)FinancialBuzz.com: Recent Developments in the World of Small Cap Companies - PR Newswire (press release)
www.prnewswire.com - January 17 at 3:20 PM
Trending Small Cap Companies With NewsTrending Small Cap Companies With News
www.prnewswire.com - January 10 at 5:53 PM
Elite Provides Update on SequestOx™ New Drug Application - GlobeNewswire (press release)Elite Provides Update on SequestOx™ New Drug Application - GlobeNewswire (press release)
globenewswire.com - December 23 at 3:12 AM
ELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Other Events, Financial Statements and ExhibitsELITE PHARMACEUTICALS INC /NV/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
biz.yahoo.com - December 22 at 10:10 PM
1:02 pm Elite Pharma updates on status of SequestOx NDA1:02 pm Elite Pharma updates on status of SequestOx NDA
us.rd.yahoo.com - December 22 at 5:08 PM
Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo - GlobeNewswire (press release)Elite Pharmaceuticals Files ANDA for Hydrocodone and Acetaminophen Combo - GlobeNewswire (press release)
globenewswire.com - December 14 at 8:44 AM

SEC Filings

Elite Pharmaceuticals (OTCMKTS:ELTP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Elite Pharmaceuticals (OTCMKTS:ELTP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Elite Pharmaceuticals (OTCMKTS ELTP) Stock Chart for Saturday, January, 20, 2018

Loading chart…

This page was last updated on 1/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.